Cancer Patients On Chemotherapy Likely Not Fully Protected By COVID-19 Vaccine

UArizona News
The immune response was much lower in cancer patients than in healthy adults, and a few of the patients had no response to the COVID-19 vaccine. This translates to less protection against SARS-CoV-2, especially the delta variant that is now the dominant strain in the United States.